Physician profile
Alan E Cowen
NPI 1649396920
$1,385.73
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $123 · 2021: $335 · 2022: $364 · 2023: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $342.10 | 2019-2023 | Lo Loestrin Fe |
| Therapeuticsmd, INC. | $122.85 | 2019-2022 | |
| Medtronic, INC. | $91.09 | 2023 | Venaseal |
| Novo Nordisk INC | $77.43 | 2019-2023 | Wegovy |
| Exeltis, USA INC. | $77.01 | 2019-2022 | |
| Organon LLC | $65.84 | 2022-2023 | Nexplanon, Jada System |
| Agile Therapeutics, INC. | $65.58 | 2021-2022 | |
| Scynexis, INC. | $62.43 | 2021-2022 | |
| Astellas Pharma US INC | $55.51 | 2019-2023 | Veozah |
| Mayne Pharma Commercial LLC | $48.11 | 2022-2023 | |
| Baxter Healthcare | $46.57 | 2022-2023 | Tisseel |
| Lupin INC. | $42.13 | 2019-2020 | |
| Millicent US INC | $33.14 | 2020 | |
| Avion Pharmaceuticals | $31.19 | 2022 | |
| Myovant Sciences INC. | $29.96 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $24.90 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.44 | 2022 | |
| Exact Sciences Corporation | $21.66 | 2023 | Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $20.99 | 2023 | Exparel |
| Evofem Biosciences, INC. | $20.46 | 2021 | |
| Hologic Sales and Service, LLC | $19.47 | 2021 | |
| Vertical Pharmaceuticals, LLC | $19.09 | 2019 | |
| Merck Sharp & Dohme LLC | $15.70 | 2019 | |
| Pfizer INC. | $14.63 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Cowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.